Menu
Back to User profile » Drs Federica Tomao
Papers published by Drs Federica Tomao:
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research
Tomao F, Boccia SM, Sassu CM, Chirra M, Palaia I, Petrella MC, Di Donato V, Colombo N, Benedetti Panici P
Cancer Management and Research 2020, 12:5479-5489
Published Date: 7 July 2020
Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
Palaia I, Tomao F, Sassu CM, Musacchio L, Benedetti Panici P
OncoTargets and Therapy 2020, 13:6109-6129
Published Date: 26 June 2020
Triple-negative breast cancer: new perspectives for targeted therapies
Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S
OncoTargets and Therapy 2015, 8:177-193
Published Date: 16 January 2015
Angiogenesis and antiangiogenic agents in cervical cancer
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
OncoTargets and Therapy 2014, 7:2237-2248
Published Date: 3 December 2014
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R, Vertechy L, Domenici L, Di Donato V, Tomao F, Muzii L, Benedetti Panici P
OncoTargets and Therapy 2014, 7:1223-1236
Published Date: 10 July 2014
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S
Therapeutics and Clinical Risk Management 2013, 9:457-462
Published Date: 11 November 2013
Current status of bevacizumab in advanced ovarian cancer
Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S
OncoTargets and Therapy 2013, 6:889-899
Published Date: 22 July 2013